Valion Bio VBIO
NASDAQ VBIO
$0.12 0.00 (-0.08%)
As of: Aug 21, 2026 · 12:55 PM EDT

Valion Bio (VBIO) Treasury Shares (2021 - 2026)

Valion Bio (VBIO) posted quarterly Treasury Shares of $12000.0 for Q4 2025, down 72.8% year-over-year from $44119.0 in Q4 2024, and down 84.89% quarter-over-quarter from $79415.0 in Q3 2025.

Valion Bio (VBIO) Treasury Shares (2021 - 2026) Analysis & Trends

Valion Bio's Treasury Shares history runs 4 years deep, the most recent figure standing at $12000.0 for Q4 2025.

  • In Q4 2025, Treasury Shares fell 72.8% year-over-year to $12000.0; the TTM figure through Dec 2025 stood at $12000.0 (down 72.8% YoY), while the FY2025 annual figure was $12000.0, down 72.8% from the prior year.
  • Treasury Shares for Q4 2025 stood at $12000.0, down from $79415.0 in the prior quarter.
  • The five-year high for Treasury Shares was $93750.0 in Q1 2022, with the low at $1009.0 in Q4 2021.
  • The 4-year median for Treasury Shares is $28059.5 (2024), against an average of $40599.8.
  • Peak annual rise in Treasury Shares reached 2017.73% in 2025, while the deepest fall reached 72.8% in 2025.
  • Valion Bio's Treasury Shares stood at $1009.0 in 2021, then surged by 9191.38% to $93750.0 in 2022, then slumped by 52.94% to $44119.0 in 2024, then sank by 72.8% to $12000.0 in 2025.
  • Business Quant data shows VBIO's Treasury Shares at $12000.0 in Q4 2025, $79415.0 in Q3 2025, and $79415.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn -
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn -
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn -
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn 8.96 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -
9 Royalty Pharma 27.31 Bn 26.47 Bn - 2.72 Mn
10 Valion Bio 410,331.63 -1.79 Mn -45,000.00 11,687.00

Historic Data

Download Data
DateValue
Jun 30, 2026 28,494.00
Jun 30, 2026 28,494.00
Dec 31, 2025 12,000.00
Dec 31, 2025 12,000.00
Sep 30, 2025 79,415.00
Sep 30, 2025 79,415.00
Jun 30, 2025 79,415.00
Jun 30, 2025 79,415.00
Mar 31, 2025 79,415.00
Mar 31, 2025 79,415.00
Dec 31, 2024 44,119.00
Dec 31, 2024 44,119.00
Sep 30, 2024 3,750.00
Sep 30, 2024 3,750.00
Jun 30, 2024 5,625.00
Jun 30, 2024 5,625.00
Mar 31, 2024 7,500.00
Mar 31, 2024 7,500.00
Mar 31, 2022 93,750.00
Mar 31, 2022 93,750.00